Trends and Disparities in Access to Buprenorphine Treatment Following an Opioid-Related Emergency Department Visit Among an Insured Cohort, 2014-2020

Maria A Stevens; Jennifer Tsai; Samuel T Savitz; Bidisha Nath; Edward R Melnick; Gail D'Onofrio; Molly Moore Jeffery

doi:10.1001/jamanetworkopen.2022.15287

Trends and Disparities in Access to Buprenorphine Treatment Following an Opioid-Related Emergency Department Visit Among an Insured Cohort, 2014-2020

JAMA Netw Open. 2022 Jun 1;5(6):e2215287. doi: 10.1001/jamanetworkopen.2022.15287.

Authors

Maria A Stevens^{1

2

3}, Jennifer Tsai⁴, Samuel T Savitz¹, Bidisha Nath⁴, Edward R Melnick⁴, Gail D'Onofrio⁴, Molly Moore Jeffery^{1

3

5}

Affiliations

¹ Department of Health Care Policy Research, Mayo Clinic, Rochester, Minnesota.
² Department of Health Policy and Management, University of North Carolina at Chapel Hill.
³ OptumLabs, Eden Prairie, Minnesota.
⁴ Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.
⁵ Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota.

Abstract

This cross-sectional study examines trends in access to buprenorphine treatment following an opioid-related emergency department (ED) visit among adults with commercial or Medicare Advantage health insurance between 2014 and 2020.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Analgesics, Opioid / therapeutic use
Buprenorphine* / therapeutic use
Emergency Service, Hospital
Humans
Narcotic Antagonists / therapeutic use
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / epidemiology

Substances

Analgesics, Opioid
Narcotic Antagonists
Buprenorphine

Abstract

Publication types

MeSH terms

Substances

Grants and funding